Last updated: July 07, 2026

Application No. 19/351,688

Untitled Application

Unknown

Filed

Priority

Dec 29, 2022 — provisional 63/477,734 +3 more

Examiner

STEELE, AMBER D

Art Unit

Tech Center

ELI LILLY AND COMPANY

Assignee

Eli Lilly and Company

OA Round

2 (Non-Final)

Interview Optional

— +9.6% interview lift. Interview lift (+9.6%) is below the 15.0% threshold. A written response is recommended.

Based on 816 resolved cases, 2023–2026

Examiner Intelligence

STEELE, AMBER D View full profile →

Grants 59% of resolved cases

Career Allowance Rate

482 granted / 816 resolved

-0.9% vs TC avg

Moderate +10% lift

Without

With

+9.6%

Interview Lift

resolved cases with interview

Typical timeline

3y 5m

Avg Prosecution

55 currently pending

Career history

872

Total Applications

across all art units

Statute-Specific Performance

§101

1.3%

-38.7% vs TC avg

§103

38.3%

-1.7% vs TC avg

§102

11.4%

-28.6% vs TC avg

§112

3.7%

-36.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 816 resolved cases

Prosecution Timeline

May 13, 2026

Non-Final Rejection mailed

Jun 12, 2026

Response Filed

Jun 30, 2026

Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/918,471

Patent 12668611

CELL-PENETRATING PEPTIDE AND USE THEREOF

3y 8m to grant Granted Jun 30, 2026

18/548,832

Patent 12655458

METHODS FOR CYCLIZATION OF (POLY)PEPTIDES COMPRISING Ny-HYDROXY- OR Ny-AMINO-L-ASPARAGINE

2y 9m to grant Granted Jun 16, 2026

18/550,098

Patent 12653869

Composition for Treatment and/or Prevention of a Corona Virus Infection

2y 9m to grant Granted Jun 16, 2026

18/549,552

Patent 12643923

METHOD OF CLARIFYING A CRUDE PROTEIN SOLUTION

2y 8m to grant Granted Jun 02, 2026

17/642,764

Patent 12612430

NEW PEPTIDES

4y 1m to grant Granted Apr 28, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3

Expected OA Rounds

59%

Grant Probability

69%

With Interview (+9.6%)

3y 5m

Median Time to Grant

Moderate

PTA Risk

Based on 816 resolved cases by this examiner. Grant probability derived from career allowance rate.